The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

EMEA (Europe, Middle East and Africa) Biopharmaceuticals Market Report 2017

EMEA (Europe, Middle East and Africa) Biopharmaceuticals Market Report 2017

Publishing Date : Oct, 2017

License Type :

Report Code : 448772

No of Pages : 100

Synopsis
In this report, the EMEA Biopharmaceuticals market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (MT), revenue (Million USD), market share and growth rate of Biopharmaceuticals for these regions, from 2012 to 2022 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Biopharmaceuticals market competition by top manufacturers/players, with Biopharmaceuticals sales volume (MT), price (USD/Kg), revenue (Million USD) and market share for each manufacturer/player; the top players including
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck

On the basis of product, this report displays the sales volume (MT), revenue (Million USD), product price (USD/Kg), market share and growth rate of each type, primarily split into
Monoclonal Antibodies
Interferon
Colony-Stimulating Factor
Erythropoietin
Insulin
Vaccines
Growth Hormones
Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (MT), market share and growth rate of Biopharmaceuticals for each application, including
Tumor
Diabetes
Cardiovascular
Hemophilia
Others

If you have any special requirements, please let us know and we will offer you the report as you want.
Index
Table of Contents

EMEA (Europe, Middle East and Africa) Biopharmaceuticals Market Report 2017
1 Biopharmaceuticals Overview
1.1 Product Overview and Scope of Biopharmaceuticals
1.2 Classification of Biopharmaceuticals
1.2.1 EMEA Biopharmaceuticals Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 EMEA Biopharmaceuticals Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Monoclonal Antibodies
1.2.4 Interferon
1.2.5 Colony-Stimulating Factor
1.2.6 Erythropoietin
1.2.7 Insulin
1.2.8 Vaccines
1.2.9 Growth Hormones
1.2.10 Others
1.3 EMEA Biopharmaceuticals Market by Application/End Users
1.3.1 EMEA Biopharmaceuticals Sales (Volume) and Market Share Comparison by Application (2012-2022
1.3.2 Tumor
1.3.3 Diabetes
1.3.4 Cardiovascular
1.3.5 Hemophilia
1.3.6 Others
1.4 EMEA Biopharmaceuticals Market by Region
1.4.1 EMEA Biopharmaceuticals Market Size (Value) Comparison by Region (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 Middle East Status and Prospect (2012-2022)
1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Biopharmaceuticals (2012-2022)
1.5.1 EMEA Biopharmaceuticals Sales and Growth Rate (2012-2022)
1.5.2 EMEA Biopharmaceuticals Revenue and Growth Rate (2012-2022)

2 EMEA Biopharmaceuticals Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Biopharmaceuticals Market Competition by Players/Manufacturers
2.1.1 EMEA Biopharmaceuticals Sales Volume and Market Share of Major Players (2012-2017)
2.1.2 EMEA Biopharmaceuticals Revenue and Share by Players (2012-2017)
2.1.3 EMEA Biopharmaceuticals Sale Price by Players (2012-2017)
2.2 EMEA Biopharmaceuticals (Volume and Value) by Type/Product Category
2.2.1 EMEA Biopharmaceuticals Sales and Market Share by Type (2012-2017)
2.2.2 EMEA Biopharmaceuticals Revenue and Market Share by Type (2012-2017)
2.2.3 EMEA Biopharmaceuticals Sale Price by Type (2012-2017)
2.3 EMEA Biopharmaceuticals (Volume) by Application
2.4 EMEA Biopharmaceuticals (Volume and Value) by Region
2.4.1 EMEA Biopharmaceuticals Sales and Market Share by Region (2012-2017)
2.4.2 EMEA Biopharmaceuticals Revenue and Market Share by Region (2012-2017)
2.4.3 EMEA Biopharmaceuticals Sales Price by Region (2012-2017)

3 Europe Biopharmaceuticals (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Biopharmaceuticals Sales and Value (2012-2017)
3.1.1 Europe Biopharmaceuticals Sales Volume and Growth Rate (2012-2017)
3.1.2 Europe Biopharmaceuticals Revenue and Growth Rate (2012-2017)
3.2 Europe Biopharmaceuticals Sales and Market Share by Type
3.3 Europe Biopharmaceuticals Sales and Market Share by Application
3.4 Europe Biopharmaceuticals Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Biopharmaceuticals Sales Volume by Countries (2012-2017)
3.4.2 Europe Biopharmaceuticals Revenue by Countries (2012-2017)
3.4.3 Germany Biopharmaceuticals Sales and Growth Rate (2012-2017)
3.4.4 France Biopharmaceuticals Sales and Growth Rate (2012-2017)
3.4.5 UK Biopharmaceuticals Sales and Growth Rate (2012-2017)
3.4.6 Russia Biopharmaceuticals Sales and Growth Rate (2012-2017)
3.4.7 Italy Biopharmaceuticals Sales and Growth Rate (2012-2017)
3.4.8 Benelux Biopharmaceuticals Sales and Growth Rate (2012-2017)

4 Middle East Biopharmaceuticals (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Biopharmaceuticals Sales and Value (2012-2017)
4.1.1 Middle East Biopharmaceuticals Sales Volume and Growth Rate (2012-2017)
4.1.2 Middle East Biopharmaceuticals Revenue and Growth Rate (2012-2017)
4.2 Middle East Biopharmaceuticals Sales and Market Share by Type
4.3 Middle East Biopharmaceuticals Sales and Market Share by Application
4.4 Middle East Biopharmaceuticals Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Biopharmaceuticals Sales Volume by Countries (2012-2017)
4.4.2 Middle East Biopharmaceuticals Revenue by Countries (2012-2017)
4.4.3 Saudi Arabia Biopharmaceuticals Sales and Growth Rate (2012-2017)
4.4.4 Israel Biopharmaceuticals Sales and Growth Rate (2012-2017)
4.4.5 UAE Biopharmaceuticals Sales and Growth Rate (2012-2017)
4.4.6 Iran Biopharmaceuticals Sales and Growth Rate (2012-2017)

5 Africa Biopharmaceuticals (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Biopharmaceuticals Sales and Value (2012-2017)
5.1.1 Africa Biopharmaceuticals Sales Volume and Growth Rate (2012-2017)
5.1.2 Africa Biopharmaceuticals Revenue and Growth Rate (2012-2017)
5.2 Africa Biopharmaceuticals Sales and Market Share by Type
5.3 Africa Biopharmaceuticals Sales and Market Share by Application
5.4 Africa Biopharmaceuticals Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Biopharmaceuticals Sales Volume by Countries (2012-2017)
5.4.2 Africa Biopharmaceuticals Revenue by Countries (2012-2017)
5.4.3 South Africa Biopharmaceuticals Sales and Growth Rate (2012-2017)
5.4.4 Nigeria Biopharmaceuticals Sales and Growth Rate (2012-2017)
5.4.5 Egypt Biopharmaceuticals Sales and Growth Rate (2012-2017)
5.4.6 Algeria Biopharmaceuticals Sales and Growth Rate (2012-2017)

6 EMEA Biopharmaceuticals Manufacturers/Players Profiles and Sales Data
6.1 Roche
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Biopharmaceuticals Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Roche Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Amgen
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Biopharmaceuticals Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Amgen Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 AbbVie
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Biopharmaceuticals Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 AbbVie Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Sanofi-Aventis
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Biopharmaceuticals Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Sanofi-Aventis Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Johnson & Johnson
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Biopharmaceuticals Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Johnson & Johnson Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Pfizer
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Biopharmaceuticals Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Pfizer Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Novo Nordisk
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Biopharmaceuticals Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Novo Nordisk Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Eli Lilly
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Biopharmaceuticals Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Eli Lilly Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Novartis
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Biopharmaceuticals Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Novartis Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Merck
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Biopharmaceuticals Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Merck Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview

7 Biopharmaceuticals Manufacturing Cost Analysis
7.1 Biopharmaceuticals Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Biopharmaceuticals

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Biopharmaceuticals Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Biopharmaceuticals Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA Biopharmaceuticals Market Forecast (2017-2022)
11.1 EMEA Biopharmaceuticals Sales, Revenue and Price Forecast (2017-2022)
11.1.1 EMEA Biopharmaceuticals Sales and Growth Rate Forecast (2017-2022)
11.1.2 EMEA Biopharmaceuticals Revenue and Growth Rate Forecast (2017-2022)
11.1.3 EMEA Biopharmaceuticals Price and Trend Forecast (2017-2022)
11.2 EMEA Biopharmaceuticals Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Biopharmaceuticals Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Biopharmaceuticals Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Biopharmaceuticals Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Biopharmaceuticals Sales Forecast by Type (2017-2022)
11.7 EMEA Biopharmaceuticals Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables
List of Tables and Figures

Figure Product Picture of Biopharmaceuticals
Figure EMEA Biopharmaceuticals Sales Volume (MT) by Type (2012-2022)
Figure EMEA Biopharmaceuticals Sales Volume Market Share by Type (Product Category) in 2016
Figure Monoclonal Antibodies Product Picture
Figure Interferon Product Picture
Figure Colony-Stimulating Factor Product Picture
Figure Erythropoietin Product Picture
Figure Insulin Product Picture
Figure Vaccines Product Picture
Figure Growth Hormones Product Picture
Figure Others Product Picture
Figure EMEA Biopharmaceuticals Sales Volume (MT) by Application (2012-2022)
Figure EMEA Sales Market Share of Biopharmaceuticals by Application in 2016
Figure Tumor Examples
Table Key Downstream Customer in Tumor
Figure Diabetes Examples
Table Key Downstream Customer in Diabetes
Figure Cardiovascular Examples
Table Key Downstream Customer in Cardiovascular
Figure Hemophilia Examples
Table Key Downstream Customer in Hemophilia
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Biopharmaceuticals Market Size (Million USD) by Region (2012-2022)
Figure Europe Biopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Biopharmaceuticals Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Biopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Biopharmaceuticals Revenue (Million USD) Status and Forecast by Countries
Figure Africa Biopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Biopharmaceuticals Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Biopharmaceuticals Sales Volume and Growth Rate (2012-2022)
Figure EMEA Biopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Biopharmaceuticals Market Major Players Product Sales Volume (MT) (2012-2017)
Table EMEA Biopharmaceuticals Sales Volume (MT) of Major Players (2012-2017)
Table EMEA Biopharmaceuticals Sales Share by Players (2012-2017)
Figure 2016 Biopharmaceuticals Sales Share by Players
Figure 2017 Biopharmaceuticals Sales Share by Players
Figure EMEA Biopharmaceuticals Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Biopharmaceuticals Revenue (Million USD) by Players (2012-2017)
Table EMEA Biopharmaceuticals Revenue Share by Players (2012-2017)
Table 2016 EMEA Biopharmaceuticals Revenue Share by Players
Table 2017 EMEA Biopharmaceuticals Revenue Share by Players
Table EMEA Biopharmaceuticals Sale Price (USD/Kg) by Players (2012-2017)
Table EMEA Biopharmaceuticals Sales (MT) and Market Share by Type (2012-2017)
Table EMEA Biopharmaceuticals Sales Share by Type (2012-2017)
Figure Sales Market Share of Biopharmaceuticals by Type (2012-2017)
Figure EMEA Biopharmaceuticals Sales Market Share by Type (2012-2017)
Table EMEA Biopharmaceuticals Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Biopharmaceuticals Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Biopharmaceuticals by Type in 2016
Table EMEA Biopharmaceuticals Sale Price (USD/Kg) by Type (2012-2017)
Table EMEA Biopharmaceuticals Sales (MT) and Market Share by Application (2012-2017)
Table EMEA Biopharmaceuticals Sales Share by Application (2012-2017)
Figure Sales Market Share of Biopharmaceuticals by Application (2012-2017)
Figure EMEA Biopharmaceuticals Sales Market Share by Application in 2016
Table EMEA Biopharmaceuticals Sales (MT) and Market Share by Region (2012-2017)
Table EMEA Biopharmaceuticals Sales Share by Region (2012-2017)
Figure Sales Market Share of Biopharmaceuticals by Region (2012-2017)
Figure EMEA Biopharmaceuticals Sales Market Share in 2016
Table EMEA Biopharmaceuticals Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Biopharmaceuticals Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Biopharmaceuticals by Region (2012-2017)
Figure EMEA Biopharmaceuticals Revenue Market Share Regions in 2016
Table EMEA Biopharmaceuticals Sales Price (USD/Kg) by Region (2012-2017)
Figure Europe Biopharmaceuticals Sales (MT) and Growth Rate (2012-2017)
Figure Europe Biopharmaceuticals Revenue and Growth Rate (2012-2017)
Table Europe Biopharmaceuticals Sales (MT) by Type (2012-2017)
Table Europe Biopharmaceuticals Market Share by Type (2012-2017)
Figure Europe Biopharmaceuticals Market Share by Type in 2016
Table Europe Biopharmaceuticals Sales (MT) by Application (2012-2017)
Table Europe Biopharmaceuticals Market Share by Application (2012-2017)
Figure Europe Biopharmaceuticals Market Share by Application in 2016
Table Europe Biopharmaceuticals Sales (MT) by Countries (2012-2017)
Table Europe Biopharmaceuticals Sales Market Share by Countries (2012-2017)
Figure Europe Biopharmaceuticals Sales Market Share by Countries (2012-2017)
Figure Europe Biopharmaceuticals Sales Market Share by Countries in 2016
Table Europe Biopharmaceuticals Revenue (Million USD) by Countries (2012-2017)
Table Europe Biopharmaceuticals Revenue Market Share by Countries (2012-2017)
Figure Europe Biopharmaceuticals Revenue Market Share by Countries (2012-2017)
Figure Europe Biopharmaceuticals Revenue Market Share by Countries in 2016
Figure Germany Biopharmaceuticals Sales (MT) and Growth Rate (2012-2017)
Figure France Biopharmaceuticals Sales (MT) and Growth Rate (2012-2017)
Figure UK Biopharmaceuticals Sales (MT) and Growth Rate (2012-2017)
Figure Russia Biopharmaceuticals Sales (MT) and Growth Rate (2012-2017)
Figure Italy Biopharmaceuticals Sales (MT) and Growth Rate (2012-2017)
Figure Benelux Biopharmaceuticals Sales (MT) and Growth Rate (2012-2017)
Figure Middle East Biopharmaceuticals Sales (MT) and Growth Rate (2012-2017)
Figure Middle East Biopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Biopharmaceuticals Sales (MT) by Type (2012-2017)
Table Middle East Biopharmaceuticals Market Share by Type (2012-2017)
Figure Middle East Biopharmaceuticals Market Share by Type (2012-2017)
Table Middle East Biopharmaceuticals Sales (MT) by Applications (2012-2017)
Table Middle East Biopharmaceuticals Market Share by Applications (2012-2017)
Figure Middle East Biopharmaceuticals Sales Market Share by Application in 2016
Table Middle East Biopharmaceuticals Sales Volume (MT) by Countries (2012-2017)
Table Middle East Biopharmaceuticals Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Biopharmaceuticals Sales Volume Market Share by Countries in 2016
Table Middle East Biopharmaceuticals Revenue (Million USD) by Countries (2012-2017)
Table Middle East Biopharmaceuticals Revenue Market Share by Countries (2012-2017)
Figure Middle East Biopharmaceuticals Revenue Market Share by Countries (2012-2017)
Figure Middle East Biopharmaceuticals Revenue Market Share by Countries in 2016
Figure Saudi Arabia Biopharmaceuticals Sales (MT) and Growth Rate (2012-2017)
Figure Israel Biopharmaceuticals Sales (MT) and Growth Rate (2012-2017)
Figure UAE Biopharmaceuticals Sales (MT) and Growth Rate (2012-2017)
Figure Iran Biopharmaceuticals Sales (MT) and Growth Rate (2012-2017)
Figure Africa Biopharmaceuticals Sales (MT) and Growth Rate (2012-2017)
Figure Africa Biopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Biopharmaceuticals Sales (MT) by Type (2012-2017)
Table Africa Biopharmaceuticals Sales Market Share by Type (2012-2017)
Figure Africa Biopharmaceuticals Sales Market Share by Type (2012-2017)
Figure Africa Biopharmaceuticals Sales Market Share by Type in 2016
Table Africa Biopharmaceuticals Sales (MT) by Application (2012-2017)
Table Africa Biopharmaceuticals Sales Market Share by Application (2012-2017)
Figure Africa Biopharmaceuticals Sales Market Share by Application (2012-2017)
Table Africa Biopharmaceuticals Sales Volume (MT) by Countries (2012-2017)
Table Africa Biopharmaceuticals Sales Market Share by Countries (2012-2017)
Figure Africa Biopharmaceuticals Sales Market Share by Countries (2012-2017)
Figure Africa Biopharmaceuticals Sales Market Share by Countries in 2016
Table Africa Biopharmaceuticals Revenue (Million USD) by Countries (2012-2017)
Table Africa Biopharmaceuticals Revenue Market Share by Countries (2012-2017)
Figure Africa Biopharmaceuticals Revenue Market Share by Countries (2012-2017)
Figure Africa Biopharmaceuticals Revenue Market Share by Countries in 2016
Figure South Africa Biopharmaceuticals Sales (MT) and Growth Rate (2012-2017)
Figure Nigeria Biopharmaceuticals Sales (MT) and Growth Rate (2012-2017)
Figure Egypt Biopharmaceuticals Sales (MT) and Growth Rate (2012-2017)
Figure Algeria Biopharmaceuticals Sales (MT) and Growth Rate (2012-2017)
Table Roche Biopharmaceuticals Basic Information List
Table Roche Biopharmaceuticals Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Roche Biopharmaceuticals Sales (MT) and Growth Rate (2012-2017)
Figure Roche Biopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Roche Biopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Amgen Biopharmaceuticals Basic Information List
Table Amgen Biopharmaceuticals Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Amgen Biopharmaceuticals Sales (MT) and Growth Rate (2012-2017)
Figure Amgen Biopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Amgen Biopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table AbbVie Biopharmaceuticals Basic Information List
Table AbbVie Biopharmaceuticals Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure AbbVie Biopharmaceuticals Sales (MT) and Growth Rate (2012-2017)
Figure AbbVie Biopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure AbbVie Biopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Sanofi-Aventis Biopharmaceuticals Basic Information List
Table Sanofi-Aventis Biopharmaceuticals Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Sanofi-Aventis Biopharmaceuticals Sales (MT) and Growth Rate (2012-2017)
Figure Sanofi-Aventis Biopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Sanofi-Aventis Biopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Johnson & Johnson Biopharmaceuticals Basic Information List
Table Johnson & Johnson Biopharmaceuticals Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Johnson & Johnson Biopharmaceuticals Sales (MT) and Growth Rate (2012-2017)
Figure Johnson & Johnson Biopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Johnson & Johnson Biopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Pfizer Biopharmaceuticals Basic Information List
Table Pfizer Biopharmaceuticals Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Pfizer Biopharmaceuticals Sales (MT) and Growth Rate (2012-2017)
Figure Pfizer Biopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Pfizer Biopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Novo Nordisk Biopharmaceuticals Basic Information List
Table Novo Nordisk Biopharmaceuticals Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Novo Nordisk Biopharmaceuticals Sales (MT) and Growth Rate (2012-2017)
Figure Novo Nordisk Biopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Novo Nordisk Biopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Eli Lilly Biopharmaceuticals Basic Information List
Table Eli Lilly Biopharmaceuticals Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Eli Lilly Biopharmaceuticals Sales (MT) and Growth Rate (2012-2017)
Figure Eli Lilly Biopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Eli Lilly Biopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Novartis Biopharmaceuticals Basic Information List
Table Novartis Biopharmaceuticals Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Novartis Biopharmaceuticals Sales (MT) and Growth Rate (2012-2017)
Figure Novartis Biopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Novartis Biopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Merck Biopharmaceuticals Basic Information List
Table Merck Biopharmaceuticals Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Merck Biopharmaceuticals Sales (MT) and Growth Rate (2012-2017)
Figure Merck Biopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Merck Biopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biopharmaceuticals
Figure Manufacturing Process Analysis of Biopharmaceuticals
Figure Biopharmaceuticals Industrial Chain Analysis
Table Raw Materials Sources of Biopharmaceuticals Major Manufacturers in 2016
Table Major Buyers of Biopharmaceuticals
Table Distributors/Traders List
Figure EMEA Biopharmaceuticals Sales (MT) and Growth Rate Forecast (2017-2022)
Figure EMEA Biopharmaceuticals Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Biopharmaceuticals Price (USD/Kg) and Trend Forecast (2017-2022)
Table EMEA Biopharmaceuticals Sales (MT) Forecast by Region (2017-2022)
Figure EMEA Biopharmaceuticals Sales Market Share Forecast by Region (2017-2022)
Table EMEA Biopharmaceuticals Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Biopharmaceuticals Revenue Market Share Forecast by Region (2017-2022)
Table Europe Biopharmaceuticals Sales (MT) Forecast by Countries (2017-2022)
Figure Europe Biopharmaceuticals Sales Market Share Forecast by Countries (2017-2022)
Table Europe Biopharmaceuticals Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Biopharmaceuticals Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Biopharmaceuticals Sales (MT) Forecast by Countries (2017-2022)
Figure Middle East Biopharmaceuticals Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Biopharmaceuticals Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Biopharmaceuticals Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Biopharmaceuticals Sales (MT) Forecast by Countries (2017-2022)
Figure Africa Biopharmaceuticals Sales Market Share Forecast by Countries (2017-2022)
Table Africa Biopharmaceuticals Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Biopharmaceuticals Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Biopharmaceuticals Sales (MT) Forecast by Type (2017-2022)
Figure EMEA Biopharmaceuticals Sales Market Share Forecast by Type (2017-2022)
Table EMEA Biopharmaceuticals Sales (MT) Forecast by Application (2017-2022)
Figure EMEA Biopharmaceuticals Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Published By : QY Research